| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 351,623 | 344,332 | 352,834 | 385,987 | | Cost of Revenue | 173,143 | 170,966 | 170,824 | 199,164 | | | Gross Profit | 178,480 | 173,366 | 182,010 | 186,823 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 135,887 | 131,447 | 122,394 | 142,901 | | Non Recurring | 5,041 | (21) | 292 | 1,600 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 37,552 | 41,940 | 59,324 | 42,322 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 525 | 827 | 1,480 | 3,297 | | Earnings Before Interest And Taxes | 38,077 | 42,767 | 60,804 | 45,619 | | Interest Expense | 148 | 168 | 188 | 187 | | Income Before Tax | 37,929 | 42,599 | 60,616 | 45,432 | | Income Tax Expense | 10,608 | 14,769 | 29,319 | 25,257 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 27,321 | 27,830 | 31,297 | 20,175 | | | Non-recurring Events | | Discontinued Operations | 658 | 248 | 357 | 126,912 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,979 | 28,078 | 31,654 | 147,087 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $27,979 | $28,078 | $31,654 | $147,087 |
|
0.51% Nasdaq 
Income Statement
